Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Research Article

JCR. 2021; 8(2): 1740-1743


COMPARISON OF IN VITRO EFFICACY OF ANTIBIOTICS AGAINST 103 CLINICAL ISOLATES OF PSEUDOMONAS AERUGINOSA

Qandeel Abbas Soomro, Nabi Mirjut, 2Babar Aijaz Memon, Asim Patrick, Abdul Sami Dahri, Bushra Hussain.

Abstract
Introduction: Pseudomonas aeruginosa is one of the most common hospital acquired infections in our setups.
Due to increasing resistance of the organism, the mortality and morbidity of the patient is also increasing.
Detection of the organism is very important to manage the diseases caused by organism.
Objective: To evaluate the in vitro efficacy of various anti-Pseudomonas antibiotics by paper disk diffusion
method against Pseudomonas aeruginosa isolated from various clinical specimens and to identify appropriate
antimicrobial in our setups.
Patients and Methods: It was a prospective study conducted at Department of Pathology, Indus Medical
College Tando Muhammad Khan for the period of 6 months. A total of 103 strains of Pseudomonas aeruginosa
were studied using various clinical specimens. Antimicrobial agents used were Carbenicillin (CAR), Piperacillin
(PIP), Imipenem (IMI), Aztreonam (AZT), Gentamicin (GEN), Tobramycin (TOB), Amikacin (AMI),
Ceftazidine (CAZ), Ofloxacin (OFL), Cipiprofloxacin (CIP) and Enoxacin (ENO).
Results: Amikacin, Ceftazidime, Imipenem, Pipercillin, Aztreonam, Ciprofloxacin, Enoxacin, Carbenicillin,
Ofloxacin, Tobramycin and Gentamicin were sensitive in percentages as92.23%, 87.3%), 83.5%, 80.6%, 73.7%,
64%, 60%, 53.3%, 47.5%, 40.7% and 39.8 % respectively.
Conclusion: This study shows that use of Carbenicillin, Ciprofloxacin, Enoxacin, Ofloxacin, Tobramycin and
Gentamicin against Pseudomonas aeruginosa on empirical basis will not be without the risk of treatment failure.

Key words: Pseudomonas aureginosa, antibiotics, hospital acquired infections



Similar Articles

Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites